Rock Springs Capital Management LP Q1 2016 Filing
Filed May 16, 2016
Portfolio Value
$1.2T
Holdings
127
Report Date
Q1 2016
Filing Type
13F-HR
All Holdings (127 positions)
| Stock | Value |
|---|---|
—ENDOCHOICE HLDGS INC | $3.1M |
RIGLUSDRIGEL PHARMACEUTICALS INC | $3.0M |
—AURIS MED HLDG AG | $2.9M |
SCYXEURSCYNEXIS INC | $2.6M |
SRPTSAREPTA THERAPEUTICS INC | $2.6M |
CLVSEURCLOVIS ONCOLOGY INC | $2.4M |
—ALDER BIOPHARMACEUTICALS INC | $2.4M |
—DBV TECHNOLOGIES S A | $2.4M |
BHCVALEANT PHARMACEUTICALS INTL | $2.2M |
—OPHTHOTECH CORP | $2.2M |
—DIMENSION THERAPEUTICS INC | $2.1M |
—EGALET CORP | $2.1M |
—NIVALIS THERAPEUTICS INC | $2.0M |
ASMBASSEMBLY BIOSCIENCES INC | $2.0M |
TTPHEURTETRAPHASE PHARMACEUTICALS I | $1.9M |
—ATYR PHARMA INC | $1.7M |
—CERULEAN PHARMA INC | $1.7M |
—ANTHERA PHARMACEUTICALS INC | $1.6M |
INFIQINFINITY PHARMACEUTICALS INC | $1.4M |
ICPTUSDINTERCEPT PHARMACEUTICALS IN | $1.3M |
GBTUSDGLOBAL BLOOD THERAPEUTICS IN | $1.2M |
—OREXIGEN THERAPEUTICS INC | $930K |
PBYIPUMA BIOTECHNOLOGY INC | $925K |
SPHSEURSOPHIRIS BIO INC | $905K |
—WRIGHT MED GROUP INC | $898K |
—BLUEBIRD BIO INC | $850K |
—MIRNA THERAPEUTICS INC | $656K |
PreviousPage 2 of 2